within Pharmacolibrary.Drugs.ATC.N;

model N02AJ01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.75,
    Cl             = 22 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 500 / 1000000,
    adminCount     = 1,
    Vd             = 0.0027,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.013333333333333334,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Dihydrocodeine and paracetamol is a fixed combination analgesic used for the management of moderate to severe pain. Dihydrocodeine is a semi-synthetic opioid analgesic, while paracetamol (acetaminophen) is a widely used non-opioid analgesic and antipyretic. This combination is approved and used in many countries for pain relief, though availability and regulation may vary by country.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated for typical adult, healthy volunteers, both sexes, oral administration. No direct published studies describing pharmacokinetics of the fixed combination found; estimates are based on individual components from referenced literature.</p><h4>References</h4><ol><li><p>Wiffen, PJ, et al., &amp; Moore, RA (2017). Tramadol with or without paracetamol (acetaminophen) for cancer pain. <i>The Cochrane database of systematic reviews</i> 5(5) CD012508–None. DOI:<a href=&quot;https://doi.org/10.1002/14651858.CD012508.pub2&quot;>10.1002/14651858.CD012508.pub2</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/28510996/&quot;>https://pubmed.ncbi.nlm.nih.gov/28510996</a></p></li><li><p>Friedel, HA, &amp; Fitton, A (1993). Flupirtine. A review of its pharmacological properties, and therapeutic efficacy in pain states. <i>Drugs</i> 45(4) 548–569. DOI:<a href=&quot;https://doi.org/10.2165/00003495-199345040-00007&quot;>10.2165/00003495-199345040-00007</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7684675/&quot;>https://pubmed.ncbi.nlm.nih.gov/7684675</a></p></li><li><p>Kirkwood, LC, et al., &amp; Somogyi, AA (1998). Glucuronidation of dihydrocodeine by human liver microsomes and the effect of inhibitors. <i>Clinical and experimental pharmacology &amp; physiology</i> 25(3-4) 266–270. DOI:<a href=&quot;https://doi.org/10.1111/j.1440-1681.1998.t01-19-.x&quot;>10.1111/j.1440-1681.1998.t01-19-.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/9590580/&quot;>https://pubmed.ncbi.nlm.nih.gov/9590580</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end N02AJ01;
